NewGenIvf Group Ltd Files January 2025 6-K Report
Ticker: NIVFW · Form: 6-K · Filed: Jan 21, 2025 · CIK: 1981662
| Field | Detail |
|---|---|
| Company | Newgenivf Group LTD (NIVFW) |
| Form Type | 6-K |
| Filed Date | Jan 21, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, company-update
TL;DR
NewGenIvf Group Ltd (formerly ASPAC I Mini Acquisition Corp.) filed its January 6-K, including a press release. Check for updates.
AI Summary
NewGenIvf Group Limited filed a Form 6-K on January 21, 2025, reporting for the month of January 2025. The filing includes a press release as Exhibit 99.1. The company, formerly known as ASPAC I Mini Acquisition Corp. until June 14, 2023, is based in Bangkok, Thailand, and its principal executive offices are located at 36/39-36/40, 13th Floor, PS Tower, Sukhumvit 21 Road (Asoke), Bangkok 10110. The filing indicates the registrant files annual reports under Form 20-F.
Why It Matters
This filing provides an update on the company's reporting status and includes a press release, which may contain material information for investors.
Risk Assessment
Risk Level: low — This filing is a routine report of foreign private issuer and does not contain specific financial disclosures or significant operational updates that would indicate high risk.
Key Players & Entities
- NewGenIvf Group Limited (company) — Registrant
- ASPAC I Mini Acquisition Corp. (company) — Former company name
- January 21, 2025 (date) — Filing date
- Wing Fung Alfred Siu (person) — Signatory for the company
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report for the month of January 2025 and to include a press release as Exhibit 99.1, as required for a foreign private issuer.
When did NewGenIvf Group Limited change its name?
NewGenIvf Group Limited changed its name from ASPAC I Mini Acquisition Corp. on June 14, 2023.
Where are NewGenIvf Group Limited's principal executive offices located?
The principal executive offices of NewGenIvf Group Limited are located at 36/39-36/40, 13th Floor, PS Tower, Sukhumvit 21 Road (Asoke), Bangkok 10110, Thailand.
Which form does the registrant use for its annual reports?
The registrant, NewGenIvf Group Limited, files its annual reports under Form 20-F.
Who signed this report on behalf of NewGenIvf Group Limited?
Wing Fung Alfred Siu signed this report on behalf of NewGenIvf Group Limited.
Filing Stats: 160 words · 1 min read · ~1 pages · Grade level 12.6 · Accepted 2025-01-21 06:07:08
Filing Documents
- ea0228147-6k_newgen.htm (6-K) — 11KB
- ea022814701ex99-1_newgen.htm (EX-99.1) — 12KB
- ex99-1_001.jpg (GRAPHIC) — 1KB
- 0001213900-25-004737.txt ( ) — 25KB
From the Filing
OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2025 Commission File Number: 001-42004 NEWGENIVF GROUP LIMITED 36/39-36/40, 13th Floor, PS Tower Sukhumvit 21 Road (Asoke) K hlong Toei Nuea Sub-district Watthana District, Bangkok 10110 Thailand (Address of Principal Executive Offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F EXHIBIT INDEX Exhibit No. Description 99.1 Press release 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: January 21, 2025 NewGenIvf Group Limited By: /s/ Wing Fung Alfred Siu Name: Wing Fung Alfred Siu Title: Chairman of the Board and Director 2